Omnicell, Inc.
NASDAQ:OMCLMedical - Healthcare Information Services
-$0.58 today
- Market cap
- $1.59B
- Beta
- 0.96
- P/E (TTM)
- 84.1
- EPS (TTM)
- $0.45
Volume 0.34M
Average 0.57M
OMCL Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Omnicell, Inc.NASDAQ: OMCL
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns positive
Q1 FY2026 net income was $11.36M, compared with -$7.02M a year earlier. Trailing-twelve-month net income was $20.43M. Over 3 fiscal years it compounded at -28.6% a year.
Context
- Net income amounted to 0.2% of revenue in FY2025, down 1.0 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 6 analysts of $114.93M (+5501.0%) for the fiscal year ending Dec 2026, a step up from the -83.6% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $11.36M+660.6% QoQ
- Last fiscal yearDec 2025
- $2.05M-83.6% YoY
- LTMMar 2026
- $20.43M-3.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +261.7% | +285.2% | +23.5 pp |
| 1 year | -83.6% | +5501.0% | +5584.6 pp |
| 3-year CAGR | -28.6% | +277.6% | +306.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 2.05M USD
- Year-over-year change
- -83.6%
- 4-year CAGR
- -59.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.05M | -83.6% |
| FY2024 | 2024-12-31 | 12.53M | +161.5% |
| FY2023 | 2023-12-31 | (20.37M) | -460.7% |
| FY2022 | 2022-12-31 | 5.65M | -92.7% |
| FY2021 | 2021-12-31 | 77.85M | — |
Net Income vs competitors
How OMCL compares with its peers on the latest reported figures
- OMCL's LTM Mar 2026 net income of $20.43M is the 9th largest of the 11 companies compared; the peer median is $15.38M.
- Its year-over-year change of -3.5% is the 5th highest of 11, against a peer median of -18.9%.
- Net income amounts to 1.7% of revenue for OMCL, versus a peer median of 8.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $171.15M | -83.1% | -75.5% | 6.8% | |
| LTM Jun 2026 | $102.87M | +93.6% | +24.5% | 7.8% | |
| LTM Jun 2026 | $75.13M | -11.2% | -36.0% | 12.2% | |
| LTM Jun 2026 | $72.3M | +7.7% | +17.8% | 11.4% | |
| LTM Sep 2026 | $44.01M | +125.0% | -11.5% | 16.3% | |
| LTM Mar 2026 | $32.29M | -26.6% | -19.3% | 0.9% | |
| LTM Mar 2026 | $24.24M | -35.6% | -43.9% | 8.6% | |
| LTM Mar 2026 | $20.56M | -27.7% | — | 2.6% | |
| LTM Mar 2026 | $20.43M | -3.5% | -28.6% | 1.7% | |
| LTM Apr 2026 | $10.19M | +123.9% | — | 2.1% | |
| LTM Mar 2026 | $10.03M | -33.1% | +55.7% | 20.7% | |
| Peer median (excluding OMCL) | $15.38M | -18.9% | -15.4% | 8.2% | |
Competitors are the stored peer set for OMCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 77.85M | 5.65M | (20.37M) | 12.53M | 2.05M |
| Depreciation & Amortization | 84.93M | 99.17M | 95.56M | 89.76M | 86.63M |
| Deferred Income Tax | (3.27M) | (37.32M) | (11.05M) | (14.86M) | (1.29M) |
| Stock-Based Compensation | 53.16M | 68.25M | 55.3M | 39.32M | 44.5M |
| Change in Working Capital | (3.34M) | (73.47M) | 43.67M | 58.33M | (8.33M) |
| Accounts Receivables | (40.97M) | (60.36M) | 38.74M | (5M) | 41.42M |
| Inventory | (25.7M) | (30.12M) | 38.02M | 5.39M | (11.23M) |
| Accounts Payables | 29.08M | (7.75M) | (17.53M) | 7.21M | (9.28M) |
| Other Working Capital | 34.24M | 24.76M | (15.56M) | 50.73M | (29.25M) |
| Other Non-Cash Items | 22.48M | 15.5M | 17.98M | 2.64M | 3.74M |
| Operating Cash Flow | 231.81M | 77.78M | 181.09M | 187.72M | 127.3M |
| Capital Expenditures | (28.97M) | (60.74M) | (41.47M) | (36.46M) | (40.42M) |
| Acquisitions (Net) | (354.16M) | 2.07M | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | (15.35M) | 0 | (10.4M) | (10.17M) |
| Other Investing Activities | (29.37M) | 15.35M | 0 | (5.93M) | (9.78M) |
| Investing Cash Flow | (412.5M) | (58.67M) | (55.02M) | (52.79M) | (60.36M) |
| Debt Repayment | 0 | 0 | (2.97M) | (225.46M) | (175M) |
| Common Stock Issued | 0 | 40.18M | 23.22M | 38.58M | 16.87M |
| Common Stock Repurchased | (16.29M) | (52.21M) | 0 | 0 | (77.6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 63.65M | (8.93M) | 3.17M | (48.7M) | 17.42M |
| Financing Cash Flow | 47.36M | (20.95M) | 23.42M | (235.58M) | (218.32M) |
| Effect of Forex Changes | (974K) | (944K) | (1.35M) | (1.72M) | 3.8M |
| Net Change in Cash | (134.3M) | (2.79M) | 148.14M | (102.37M) | (147.58M) |
| Free Cash Flow | 202.84M | 17.04M | 139.62M | 151.26M | 86.89M |
Omnicell, Inc.
NASDAQ:OMCL
Intrinsic Alpha fair value
Locked
Current Price
$34.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.